Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships between Genetics and Acute Systemic and Central Nervous System BDNF Profiles

Neurorehabilitation and Neural Repair

Volumn 30, Issue 1, 2016, Pages 83-93

  Failla, Michelle D ^a   Conley, Yvette P ^a,b,c   Wagner, Amy K ^a,c,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

aging; BDNF; genetics; mortality; Rehabilomics; traumatic brain injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BIOLOGICAL MARKER; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ALLELE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; INJURY SCALE; INJURY SEVERITY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOPHYSIOLOGY; PERSISTENT VEGETATIVE STATE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; GENETICS; METABOLISM; RISK FACTOR;

ADULT; BIOMARKERS; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84983134935     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968315586465     Document Type: Article

References (73)

1. Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC,. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007; 22: 341-353.
2. Brooks JC, Strauss DJ, Shavelle RM, Paculdo DR, Hammond FM, Harrison-Felix CL,. Long-term disability and survival in traumatic brain injury: results from the National Institute on Disability and Rehabilitation Research Model Systems. Arch Phys Med Rehabil. 2013; 94: 2203-2209.
3. Susman M, DiRusso SM, Sullivan T, et al. Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma. 2002; 53: 219-223.
4. Harrison-Felix C, Whiteneck G, Devivo MJ, Hammond FM, Jha A,. Causes of death following 1 year postinjury among individuals with traumatic brain injury. J Head Trauma Rehabil. 2006; 21: 22-33.
5. Goyal A, Failla MD, Niyonkuru C, et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma. 2013; 30: 946-957.
6. Wagner AK, McCullough EH, Niyonkuru C, et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma. 2011; 28: 871-888.
7. Santarsieri M, Niyonkuru C, McCullough EH, et al. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J Neurotrauma. 2014; 31: 699-712. doi: 10.1089/neu.2013.3177.
8. Wagner AK, Amin KB, Niyonkuru C, et al. CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI. J Cereb Blood Flow Metab. 2011; 31: 1886-1896.
9. Roozenbeek B, Chiu YL, Lingsma HF, et al. Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the Brain Trauma Foundation TBI-trac® New York State database. J Neurotrauma. 2012; 29: 1306-1312.
10. Failla MD, Kumar RG, Peitzman AB, Conley YP, Ferrell RE, Wagner AK,. Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI. Neurorehabil Neural Repair. 2015; 29: 234-246. doi: 10.1177/1545968314542617.
11. Chen ZY, Patel PD, Sant G, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 2004; 24: 4401-4411.
12. Martinowich K, Lu B,. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008; 33: 73-83.
13. Blaha GR, Raghupathi R, Saatman KE, McIntosh TK,. Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits. Neuroscience. 2000; 99: 483-493.
14. Pelleymounter MA, Cullen MJ, Wellman CL,. Characteristics of BDNF-induced weight loss. Exp Neurol. 1995; 131: 229-238.
15. Kernie SG, Liebl DJ, Parada LF,. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 2000; 19: 1290-1300.
16. Wang H, Zhou XF,. Injection of brain-derived neurotrophic factor in the rostral ventrolateral medulla increases arterial blood pressure in anaesthetized rats. Neuroscience. 2002; 112: 967-975.
17. Brady R, Zaidi SI, Mayer C, Katz DM,. BDNF is a target-derived survival factor for arterial baroreceptor and chemoafferent primary sensory neurons. J Neurosci. 1999; 19: 2131-2142.
18. Wan R, Weigand LA, Bateman R, Griffioen K, Mendelowitz D, Mattson MP,. Evidence that BDNF regulates heart rate by a mechanism involving increased brainstem parasympathetic neuron excitability. J Neurochem. 2014; 129: 573-580. doi: 10.1111/jnc.12656.
19. Alexander N, Osinsky R, Schmitz A, Mueller E, Kuepper Y, Hennig J,. The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress. Psychoneuroendocrinology. 2012; 35: 949-953.
20. Shalev I, Lerer E, Israel S, et al. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology. 2009; 34: 382-388.
21. Yang AC, Chen TJ, Tsai SJ, et al. BDNF Val66Met polymorphism alters sympathovagal balance in healthy subjects. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B: 1024-1030.
22. Woolf PD,. Hormonal responses to trauma. Crit Care Med. 1992; 20: 216-226.
23. Santarsieri M, Kumar RG, Kochanek PM, Berga S, Wagner AK,. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun. 2015; 45: 15-27. doi: 10.1016/j.bbi.2014.09.003.
24. Barker PA,. Whither proBDNF? Nat Neurosci. 2009; 12: 105-106.
25. Barrett GL,. The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol. 2000; 61: 205-229.
26. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S,. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev. 2008; 59: 201-220.
27. Romanczyk TB, Weickert CS, Webster MJ, Herman MM, Akil M, Kleinman JE,. Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci. 2002; 15: 269-280.
28. Webster MJ, Herman MM, Kleinman JE, Shannon Weickert C,. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns. 2006; 6: 941-951.
29. Rostami E, Krueger F, Plantman S, et al. Alteration in BDNF and its receptors, full-length and truncated TrkB and p75(NTR) following penetrating traumatic brain injury. Brain Res. 2014; 1542: 195-205.
30. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003; 112: 257-269.
31. Orefice LL, Waterhouse EG, Partridge JG, Lalchandani RR, Vicini S, Xu B,. Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines. J Neurosci. 2013; 33: 11618-11632.
32. Brunoni AR, Lopes M, Fregni F,. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008; 11: 1169-1180.
33. Ritter C, Miranda AS, Giombelli VR, et al. Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury. Crit Care. 2012; 16: R234.
34. Krabbe KS, Mortensen EL, Avlund K, et al. Brain-derived neurotrophic factor predicts mortality risk in older women. J Am Geriatr Soc. 2009; 57: 1447-1452.
35. Halldén S, Sjögren M, Hedblad B, et al. Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers. Heart. 2013; 99: 949-953.
36. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ,. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998; 37: 1553-1561.
37. Pillai A, Kale A, Joshi S, et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol. 2010; 13: 535-539.
38. Terracciano A, Piras MG, Lobina M, et al. Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study. World J Biol Psychiatry. 2013; 14: 583-589.
39. Kalish H, Phillips TM,. Analysis of neurotrophins in human serum by immunoaffinity capillary electrophoresis (ICE) following traumatic head injury. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878: 194-200.
40. Wagner AK,. TBI translational rehabilitation research in the 21st century: exploring a rehabilomics research model. Eur J Phys Rehabil Med. 2010; 46: 549-556.
41. Wagner AK, Zitelli KT,. A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology. 2013; 20: 39-48. doi: 10.1016/j.pathophys.2012.02.007.
42. Baker SP, O'Neill B, Haddon W, Long WB,. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974; 14: 187-196.
43. Social Security Death Index. http://www.genealogybank.com/gbnk/ssdi/. Accessed April 30, 2015.
44. Jennett B, Bond M,. Assessment of outcome after severe brain damage. Lancet. 1975; 1: 480-484.
45. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
46. Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004; 36: 388-393.
47. Nettiksimmons J, Simonsick EM, Harris T, Satterfield S, Rosano C, Yaffe K,. The associations between serum brain-derived neurotrophic factor, potential confounders, and cognitive decline: a longitudinal study. PLoS One. 2014; 9: e91339.
48. Cox DR,. Regression models and life-tables. J R Stat Soc Ser B Methodol. 1972; 34: 187-220.
49. Chiaretti A, Piastra M, Polidori G, et al. Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med. 2003; 29: 1329-1338.
50. Hicks RR, Numan S, Dhillon HS, Prasad MR, Seroogy KB,. Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma. Brain Res Mol Brain Res. 1997; 48: 401-406.
51. Almeida RD, Manadas BJ, Melo CV, et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 2005; 12: 1329-1343.
52. Lindvall O, Kokaia Z, Bengzon J, Elmer E, Kokaia M,. Neurotrophins and brain insults. Trends Neurosci. 1994; 17: 490-496.
53. Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD,. Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatry. 1999; 67: 39-43.
54. Gomes JR, Costa JT, Melo CV, et al. Excitotoxicity downregulates TrkB.FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons. J Neurosci. 2012; 32: 4610-4622.
55. Vidaurre OG, Gascón S, Deogracias R, et al. Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity. Cell Death Dis. 2012; 3: e256.
56. Rasmussen P, Brassard P, Adser H, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009; 94: 1062-1069.
57. Dawood T, Anderson J, Barton D, et al. Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol Psychiatry. 2007; 12: 981-983.
58. Caporali A, Emanueli C,. Cardiovascular actions of neurotrophins. Physiol Rev. 2009; 89: 279-308.
59. Nakahashi T, Fujimura H, Altar CA, et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 2000; 470: 113-117.
60. Fujimura H, Altar CA, Chen R, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost. 2002; 87: 728-734.
61. Rothman SM, Griffioen KJ, Wan R, Mattson MP,. Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci. 2012; 1264: 49-63.
62. Lommatzsch M, Zingler D, Schuhbaeck K, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging. 2005; 26: 115-123.
63. Erickson KI, Prakash RS, Voss MW, et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci. 2010; 30: 5368-5375.
64. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C,. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology. 2004; 29: 83-98.
65. Cernak I, Chang T, Ahmed FA, et al. Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Dev Neurosci. 2010; 32: 442-453.
66. Oakley R, Tharakan B,. Vascular hyperpermeability and aging. Aging Dis. 2014; 5: 114-125.
67. Zuccato C, Marullo M, Vitali B, et al. Brain-derived neurotrophic factor in patients with Huntington's disease. PloS One. 2011; 6: e22966.
68. Tsuchimine S, Sugawara N, Ishioka M, Yasui-Furukori N,. Preanalysis storage conditions influence the measurement of brain-derived neurotrophic factor levels in peripheral blood. Neuropsychobiology. 2014; 69: 83-88.
69. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM,. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull. 2007; 73: 143-149.
70. Bus BA, Tendolkar I, Franke B, Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J Biol Psychiatry. 2012; 13: 39-47.
71. Piccinni A, Marazziti D, Del Debbio A, et al. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int. 2008; 25: 819-826.
72. Wise EK, Hoffman JM, Powell JM, Bombardier CH, Bell KR,. Benefits of exercise maintenance after traumatic brain injury. Arch Phys Med Rehabil. 2012; 93: 1319-1323.
73. Griesbach GS, Hovda DA, Gomez-Pinilla F,. Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res. 2009; 1288: 105-115.